Vivos Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 268

Employees

  • Stock Symbol
  • VVOS

Stock Symbol

  • Investments
  • 9

  • Share Price
  • $0.05
  • (As of Friday Closing)

Vivos Therapeutics General Information

Description

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Contact Information

Website
www.vivos.com
Formerly Known As
Corrective BioTechnologies
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Corporate Office
  • 9137 South Ridgeline Boulevard
  • Suite 210
  • Highlands Ranch, CO 80129
  • United States
+1 (866)
Primary Industry
Therapeutic Devices
Other Industries
Clinics/Outpatient Services
Stock Exchange
NAS
Corporate Office
  • 9137 South Ridgeline Boulevard
  • Suite 210
  • Highlands Ranch, CO 80129
  • United States
+1 (866)

Vivos Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivos Therapeutics Stock Performance

As of 20-Nov-2026, Vivos Therapeutics’s stock price is $0.05. Its current market cap is $1.83M with 33.8M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.06 $0.05 - $2.69 $1.83M 33.8M 14.2M -$1.35

Vivos Therapeutics Financials Summary

As of 30-Sep-2026, Vivos Therapeutics has a trailing 12-month revenue of $20.5M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 16,636 27,657 20,598 17,686
Revenue 20,532 17,443 15,031 13,801
EBITDA (20,242) (19,921) (10,555) (12,962)
Net Income (22,062) (21,230) (11,136) (13,583)
Total Assets 22,856 25,152 15,284 10,730
Total Debt 5,989 13,502 1,512 1,995
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vivos Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vivos Therapeutics‘s full profile, request access.

Request a free trial

Vivos Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a tech
Therapeutic Devices
Highlands Ranch, CO
268 As of 2026

New Taipei, Taiwan
 

Mont-Saint-Guibert, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vivos Therapeutics Competitors (5)

One of Vivos Therapeutics’s 5 competitors is Wellell, a Venture Capital-Backed company based in New Taipei, Taiwan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Wellell Venture Capital-Backed New Taipei, Taiwan
Nyxoah Formerly VC-backed Mont-Saint-Guibert, Belgium
Inspire Medical Systems Formerly VC-backed Golden Valley, MN
Somnics Venture Capital-Backed Zhubei, Taiwan
SomnoMed Formerly PE-Backed Sydney, Australia
You’re viewing 5 of 5 competitors. Get the full list »

Vivos Therapeutics Patents

Vivos Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250256056-A1 Methods, systems, and devices for the treatment of stress disorders Pending 09-Feb-2024
US-20240428920-A1 Orofacial myofunctional therapy methods and systems Pending 25-Jan-2022
WO-2023147341-A1 Orofacial myofunctional therapy methods and systems Inactive 25-Jan-2022
US-11723790-B2 Vibrational oral appliance with mandibular advancements Active 09-Nov-2021
US-12048608-B2 Vibrational oral appliance with mandibular advancements Active 09-Nov-2021 A61C7/008
To view Vivos Therapeutics’s complete patent history, request access »

Vivos Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivos Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vivos Therapeutics‘s full profile, request access.

Request a free trial

Vivos Therapeutics Investments & Acquisitions (9)

Vivos Therapeutics’s most recent deal was a Corporate with SOD Sciences for . The deal was made on 19-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SOD Sciences 19-Oct-2026 Corporate Clinics/Outpatient Services
The Sleep Center of Nevada 10-Jun-2025 Merger/Acquisition Clinics/Outpatient Services
Advanced Facialdontics (Product Rights and Intellectual Property is Based in Littleton, Colorado) 01-Mar-2023 Corporate Asset Purchase Buildings and Property
Lyon Management and Consulting (Medical Billing and Practice Management Software) 14-Apr-2021 Corporate Asset Purchase Buildings and Property
MyoCorrect 29-Mar-2021 Merger/Acquisition Other Healthcare Services
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Vivos Therapeutics ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

36.73 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Vivos Therapeutics’s complete esg history, request access »

Vivos Therapeutics Exits (1)

Vivos Therapeutics’s most recent exit was on 01-Jul-2018 from TMJ & Sleep Therapy Centre of Utah. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
TMJ & Sleep Therapy Centre of Utah 01-Jul-2018 Completed
To view Vivos Therapeutics’s complete exits history, request access »

Vivos Therapeutics Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Apex Dental Sleep Lab La Mesa, CA 2017
The Sleep Center of Nevada Las Vegas, NV 2008

Vivos Therapeutics FAQs

  • When was Vivos Therapeutics founded?

    Vivos Therapeutics was founded in 2013.

  • Where is Vivos Therapeutics headquartered?

    Vivos Therapeutics is headquartered in Highlands Ranch, CO.

  • What is the size of Vivos Therapeutics?

    Vivos Therapeutics has 268 total employees.

  • What industry is Vivos Therapeutics in?

    Vivos Therapeutics’s primary industry is Therapeutic Devices.

  • Is Vivos Therapeutics a private or public company?

    Vivos Therapeutics is a Public company.

  • What is Vivos Therapeutics’s stock symbol?

    The ticker symbol for Vivos Therapeutics is VVOS.

  • What is the current stock price of Vivos Therapeutics?

    As of 20-Nov-2026 the stock price of Vivos Therapeutics is $0.05.

  • What is the current market cap of Vivos Therapeutics?

    The current market capitalization of Vivos Therapeutics is $1.83M.

  • What is Vivos Therapeutics’s current revenue?

    The trailing twelve month revenue for Vivos Therapeutics is $20.5M.

  • Who are Vivos Therapeutics’s competitors?

    Wellell, Nyxoah, Inspire Medical Systems, Somnics, and SomnoMed are competitors of Vivos Therapeutics.

  • What is Vivos Therapeutics’s annual earnings per share (EPS)?

    Vivos Therapeutics’s EPS for 12 months was -$1.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process